Molecular profiling of signet ring cell colorectal cancer provides a strong rationale for genomic targeted and immune checkpoint inhibitor therapies

British Journal of Cancer

from Gastroenterology via xlomafota13 on Inoreader http://ift.tt/2rSZJmg
via IFTTT